The FDA has approved Inlexzo (gemcitabine intravesical system) for the treatment of adult patients with BCG-unresponsive, non-muscle invasive bladder cancer with CIS with or without papillary tumors.

Beyond GLP-1 RA prescriptions, chronic kidney disease (CKD) patients require comprehensive care from doctors, dietitians, & ...

An investigational factor XI inhibitor shows early promise for treating atrial fibrillation in patients with a degree of kidney impairment.

However, BCC rates similar by College of American Pathologists and Clinical and Laboratory Standards Institute criteria.

(HealthDay News) — Poor cardiovascular-kidney-metabolic (CKM) health is associated with an increased risk for psoriasis, especially for those with high genetic risk, according to a study published ...

Multiparametric MRI was a game changer for prostate cancer diagnosis. Now trial findings suggest a simpler imaging protocol may be as effective.

The committee found strong evidence that glucagon-like peptide-1 (GLP-1) receptor agonists benefit people with type 2 diabetes, particularly those with heart or kidney disease, by improving glucose ...

Insomnia linked to faster decline in global cognition scores and increased risk for cognitive impairment in older adults.

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

Pure membranous lupus nephritis is understudied, so investigators examined its clinical characteristics, risk of progressive kidney dysfunction, and treatment goals.

Study findings support intensive blood pressure control in patients with hypertension without chronic kidney disease at baseline.

As changes to Medicare Part D prescription drug coverage have taken effect with implementation of the IRA, concurrent changes in plan design have increased cost-sharing burdens for patients, data ...